| |
| |
|
| Insider
Information: |
Love Richard L |
| Relationship: |
Director |
| City: |
San Antonio |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
122,528 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$670,126 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
122,528 |
|
|
| Total
Value |
$670,126 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2003-10-24 |
0 |
Premium* |
|
|
Imarx Therapeutics Inc |
SEGI |
Director |
2008-05-30 |
48,810 |
2007-07-26 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2017-09-29 |
73,718 |
2007-09-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRXL |
PAREXEL International |
Director |
– • – |
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(88,302) |
0 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2017-09-29 |
4 |
S |
$3.20 |
$3,123 |
D/D |
(976) |
73,718 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2017-09-28 |
4 |
S |
$3.19 |
$43,714 |
D/D |
(13,624) |
74,694 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2017-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,823 |
88,302 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2017-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,736 |
88,318 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2016-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,369 |
86,479 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
535,824 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2016-03-30 |
4 |
AS |
$62.50 |
$83,125 |
D/D |
(1,330) |
84,110 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2015-12-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,320) |
472,129 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2015-12-01 |
4 |
AS |
$68.21 |
$90,719 |
D/D |
(1,330) |
85,440 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2015-09-30 |
4 |
S |
$1.45 |
$19,853 |
D/D |
(13,660) |
530,449 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2015-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
86,770 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2015-09-01 |
4 |
S |
$64.26 |
$85,466 |
D/D |
(1,330) |
84,350 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2015-05-14 |
4 |
S |
$65.00 |
$325,000 |
D/D |
(5,000) |
85,680 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2014-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,662 |
90,680 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2014-08-11 |
4 |
S |
$57.33 |
$343,980 |
D/D |
(6,000) |
88,018 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
34,844 |
544,109 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2014-03-07 |
4 |
S |
$3.75 |
$150,973 |
D/D |
(40,000) |
509,265 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
549,265 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2013-12-17 |
4 |
S |
$1.71 |
$10,266 |
D/D |
(6,000) |
403,265 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2013-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,277 |
94,018 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2013-08-28 |
4 |
S |
$47.04 |
$235,200 |
D/D |
(5,000) |
90,741 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
409,265 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2013-05-24 |
4 |
S |
$1.21 |
$27,853 |
D/D |
(23,000) |
322,308 |
0 |
- |
|
| PRXL |
PAREXEL International |
Director |
• • – |
2013-05-20 |
4 |
S |
$46.65 |
$373,200 |
D/D |
(8,000) |
95,741 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
